These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16681424)

  • 1. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.
    Pfützner A; Standl E; Strotmann HJ; Schulze J; Hohberg C; Lübben G; Pahler S; Schöndorf T; Forst T
    Clin Chem Lab Med; 2006; 44(5):556-60. PubMed ID: 16681424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus.
    Pfützner A; Forst T
    Diabetes Technol Ther; 2006 Feb; 8(1):28-36. PubMed ID: 16472048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
    Anan F; Takahashi N; Nakagawa M; Ooie T; Saikawa T; Yoshimatsu H
    Metabolism; 2005 Apr; 54(4):552-8. PubMed ID: 15798966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with type 2 diabetes mellitus.
    Anan F; Masaki T; Shimomura T; Fujiki M; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Metabolism; 2011 Apr; 60(4):460-6. PubMed ID: 20537668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and incident diabetes in patients with arterial disease.
    Verhagen SN; Wassink AM; van der Graaf Y; Visseren FL;
    Eur J Clin Invest; 2013 Oct; 43(10):1052-9. PubMed ID: 23919838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.
    Anan F; Masaki T; Kikuchi H; Iwao T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Diabetes Res Clin Pract; 2010 Feb; 87(2):233-9. PubMed ID: 19931932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any association of serum high-sensitivity C-reactive protein with various risk factors for metabolic syndrome in a healthy adult population of karachi, pakistan?
    Riaz M; Fawwad A; Hydrie MZ; Basit A; Shera AS
    Metab Syndr Relat Disord; 2011 Jun; 9(3):177-82. PubMed ID: 21247270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
    El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
    Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.
    Hohberg C; Pfützner A; Forst T; Lübben G; Karagiannis E; Borchert M; Schöndorf T
    Diabetes Obes Metab; 2009 May; 11(5):464-71. PubMed ID: 19422402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between baseline high sensitivity C-reactive protein level and the first cardio-cerebral vascular event in diabetic population: a prospective cohort study].
    Wang LY; Wu SL; Yang XL; Wang TJ; Su LR; Gao JS; Zheng XM; Liu XR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):749-54. PubMed ID: 22169424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
    Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury.
    Lee MY; Myers J; Hayes A; Madan S; Froelicher VF; Perkash I; Kiratli BJ
    J Spinal Cord Med; 2005; 28(1):20-5. PubMed ID: 15832900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperleptinaemia, insulin resistance and survival in peritoneal dialysis patients.
    Cao L; Mou S; Fang W; Gu L; Huang J; Gu A; Qian J; Ni Z
    Nephrology (Carlton); 2015 Sep; 20(9):617-24. PubMed ID: 25907108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.